NP SWAB DRIVE THROUGH COVID-19 TESTING AT CHLA

We now accept Blood Anti-SARS-CoV-2 Antibody IgG Testing at our drive through location. 

Click here for more information.  Please note that this test requires a venipuncture blood draw.  The family will be directly to the phlebotomy tent to have the sample drawn safely.

REMINDER: Please be sure to fill out all demographic and insurance information.

Update - September 10, 2020

COVID-19 lab results are available on the MyCHLAPortal.

Update - August 7, 2020

 

CHLA requires all patients receiving the nasopharyngeal swab COVID-19 testing to complete the CHLA Consent & Test Release Authorization. Patients will receive and complete this form when they arrive at the testing facility. This consent will be signed prior to any procedure/test and allows CHLA to perform and facilitate certain contact tracing activities. For more information, please refer to the Consent FAQ Flier.

In an effort to support you amid the COVID-19 crisis, CHLA offers testing for patients of Care Network members who meet testing criteria.  Specimen collections will be at the CHLA Drive-Through Covid-19 Testing Clinic. 

 

Testing criteria have been developed with Infectious Disease faculty and the Infection Control and Prevention team at CHLA.  These criteria were designed for Care Network practices and are included below and in the attached. 

 

  • Asymptomatic patients should be tested if they are medically fragile (e.g. severe asthma, congenital immunodeficiency, poorly controlled asthma that leads to frequent urgent care or ED visits) AND have been exposed to someone in their household who has tested positive

 

  • Symptomatic patients (URI, fever, feeling ill, diarrhea) should be tested if test results would have implications for clinical management. Testing is indicated if they meet one of the following:

  1. Patient has unrelated developing illness that would likely lead to hospital admission in the next week

  2. Patient is medically fragile (e.g. severe asthma, congenital immunodeficiency, poorly controlled asthma that leads to frequent urgent care or ED visits)

  3. Patient lives or spends substantial time with a medically fragile individual whereby testing positive would lead to a change in social distancing or living arrangements

 

Relevant documents for your practice and patients are linked below.  Specifically, the ordering provider will need to fill out the highlighted fields in the lab requisition form.  The patient will need to bring with them the completed form, insurance information, and the document titled “CHLA COVID-19 Drive-Through Directions and Instructions.” 

 

Prior to sending a patient to the drive-through testing clinic, we request you review all attached documents to ensure criteria for testing is met and associated forms are complete. If you are sending a patient to the clinic, please make sure to inform Felicia Hoodbhoy at fhoodbhoy@chla.usc.edu or 714-383-0751.

 

Please note that the clinic is open Monday through Friday, from 6:00 a.m. – 2:00 p.m. 

For cash pay patients, the fee will be $96. 

Results will be faxed to your office 24 hours after the lab receives the sample. It is then the responsibility of the provider to share results with the patient and/or family and inform the local County Department of Public Health of a positive test result. Sample scripts for notifying patients are also attached.

COVID-19 TESTING FOR PHYSICIANS AND STAFF

CHLA accepts Care Network providers and their staff for COVID-19 lab testing at the drive through facility. Prior to arriving at the drive-through testing clinic, we request you review the “Care Network Covid-19 Testing Provider Information Form” to ensure criteria for testing is met and, if so, please be sure to complete and bring all associated forms. Please note that providers must have the Clinical Requisition Form completed by a referring physician and cannot self-refer to the clinic. If you are faxing the requisition to the patient, please be sure to circle the highlighted testing as it may not show up on a fax. If you or a staff member will be going to the clinic, please make sure to inform Felicia Hoodbhoy at fhoodbhoy@chla.usc.edu or 714-383-0751.

CODING INFORMATION

87635 novel coronavirus tests through infectious agent detection by nucleic acid.

For more information on CDC ICD COVID-19 guidelines, please click here.  

Please note that with the early release of these CPT codes, the health plans need to manually upload these code descriptors into their claims system and fee schedules. This delay may result in processing errors. If you experience claim errors, please reach out to Anahit Petrosyan at anapetrosyan@chla.usc.edu.

©2020 by CHLA Health Network. Proudly created with Wix.com